BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 24417613)

  • 1. Role of small intestinal bacterial overgrowth in severe small intestinal damage in chronic non-steroidal anti-inflammatory drug users.
    Muraki M; Fujiwara Y; Machida H; Okazaki H; Sogawa M; Yamagami H; Tanigawa T; Shiba M; Watanabe K; Tominaga K; Watanabe T; Arakawa T
    Scand J Gastroenterol; 2014 Mar; 49(3):267-73. PubMed ID: 24417613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-tumour necrosis factor agents reduce non-steroidal anti-inflammatory drug-induced small bowel injury in rheumatoid arthritis patients.
    Watanabe T; Tanigawa T; Shiba M; Nadatani Y; Nagami Y; Sugimori S; Yamagami H; Watanabe K; Tominaga K; Fujiwara Y; Koike T; Arakawa T
    Gut; 2014 Mar; 63(3):409-14. PubMed ID: 23697473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between chronic use of proton pump inhibitors and small- intestinal bacterial overgrowth assessed using lactulose hydrogen breath tests.
    Fujiwara Y; Watanabe T; Muraki M; Yamagami H; Tanigawa T; Shiba M; Tominaga K; Arakawa T
    Hepatogastroenterology; 2015; 62(138):268-72. PubMed ID: 25916046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for severe nonsteroidal anti-inflammatory drug-induced small intestinal damage.
    Watanabe T; Tanigawa T; Nadatani Y; Nagami Y; Sugimori S; Okazaki H; Yamagami H; Watanabe K; Tominaga K; Fujiwara Y; Koike T; Arakawa T
    Dig Liver Dis; 2013 May; 45(5):390-5. PubMed ID: 23333664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-specific multiple ulcers of the small intestine unrelated to non-steroidal anti-inflammatory drugs.
    Matsumoto T; Iida M; Matsui T; Yao T; Watanabe H; Yao T; Okabe H
    J Clin Pathol; 2004 Nov; 57(11):1145-50. PubMed ID: 15509673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lactulose Hydrogen Breath Test Result Is Associated with Age and Gender.
    Newberry C; Tierney A; Pickett-Blakely O
    Biomed Res Int; 2016; 2016():1064029. PubMed ID: 27073800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visible small-intestinal mucosal injury in chronic NSAID users.
    Graham DY; Opekun AR; Willingham FF; Qureshi WA
    Clin Gastroenterol Hepatol; 2005 Jan; 3(1):55-9. PubMed ID: 15645405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lactulose hydrogen breath test in small intestinal bacterial overgrowth].
    Wang J; Bei L; Pan G
    Zhonghua Nei Ke Za Zhi; 1995 Jun; 34(6):381-4. PubMed ID: 8582184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of hydrogen breath tests in diagnosis of small intestinal bacterial overgrowth in malabsorption syndrome and its relationship with oro-cecal transit time.
    Ghoshal UC; Ghoshal U; Das K; Misra A
    Indian J Gastroenterol; 2006; 25(1):6-10. PubMed ID: 16567886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term effects of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 selective agents on the small bowel: a cross-sectional capsule enteroscopy study.
    Maiden L; Thjodleifsson B; Seigal A; Bjarnason II; Scott D; Birgisson S; Bjarnason I
    Clin Gastroenterol Hepatol; 2007 Sep; 5(9):1040-5. PubMed ID: 17625980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Term Outcomes of NSAID-Induced Small Intestinal Injury Assessed by Capsule Endoscopy in Korea: A Nationwide Multicenter Retrospective Study.
    Shim KN; Song EM; Jeen YT; Kim JO; Jeon SR; Chang DK; Song HJ; Lim YJ; Kim JS; Ye BD; Park CH; Jeon SW; Cheon JH; Lee KJ; Kim JH; Jang BI; Moon JS; Chun HJ; Choi MG;
    Gut Liver; 2015 Nov; 9(6):727-33. PubMed ID: 25473079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical features of NSAID-induced small intestinal damage].
    Sugimori S; Watanabe T; Shiba M; Higuchi K; Arakawa T
    Nihon Rinsho; 2007 Oct; 65(10):1862-5. PubMed ID: 17926537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of small bowel injury in patients with rheumatoid arthritis by capsule endoscopy: effects of anti-rheumatoid arthritis drugs.
    Sugimori S; Watanabe T; Tabuchi M; Kameda N; Machida H; Okazaki H; Tanigawa T; Yamagami H; Shiba M; Watanabe K; Tominaga K; Fujiwara Y; Oshitani N; Koike T; Higuchi K; Arakawa T
    Digestion; 2008; 78(4):208-13. PubMed ID: 19142000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of nonsteroidal anti-inflammatory drug-induced small-intestinal injury by prostaglandin: a pilot randomized controlled trial evaluated by capsule endoscopy.
    Fujimori S; Seo T; Gudis K; Ehara A; Kobayashi T; Mitsui K; Yonezawa M; Tanaka S; Tatsuguchi A; Sakamoto C
    Gastrointest Endosc; 2009 Jun; 69(7):1339-46. PubMed ID: 19243767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of small intestinal mucosal injuries as a result of NSAID administration.
    Fujimori S; Gudis K; Takahashi Y; Seo T; Yamada Y; Ehara A; Kobayashi T; Mitsui K; Yonezawa M; Tanaka S; Tatsuguchi A; Sakamoto C
    Eur J Clin Invest; 2010 Jun; 40(6):504-10. PubMed ID: 20412292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small-intestinal bacterial overgrowth in cirrhosis is related to the severity of liver disease.
    Pande C; Kumar A; Sarin SK
    Aliment Pharmacol Ther; 2009 Jun; 29(12):1273-81. PubMed ID: 19302262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of lactulose and glucose breath test for diagnosis of small intestinal bacterial overgrowth in patients with irritable bowel syndrome.
    Rana SV; Sharma S; Kaur J; Sinha SK; Singh K
    Digestion; 2012; 85(3):243-7. PubMed ID: 22472730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors of symptomatic NSAID-induced small intestinal injury and diaphragm disease.
    Ishihara M; Ohmiya N; Nakamura M; Funasaka K; Miyahara R; Ohno E; Kawashima H; Itoh A; Hirooka Y; Watanabe O; Ando T; Goto H
    Aliment Pharmacol Ther; 2014 Sep; 40(5):538-47. PubMed ID: 25041257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microbiota Plays a Key Role in Non-Steroidal Anti-Inflammatory Drug-Induced Small Intestinal Damage.
    Otani K; Tanigawa T; Watanabe T; Shimada S; Nadatani Y; Nagami Y; Tanaka F; Kamata N; Yamagami H; Shiba M; Tominaga K; Fujiwara Y; Arakawa T
    Digestion; 2017; 95(1):22-28. PubMed ID: 28052268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention and management of non-steroidal anti-inflammatory drugs-induced small intestinal injury.
    Park SC; Chun HJ; Kang CD; Sul D
    World J Gastroenterol; 2011 Nov; 17(42):4647-53. PubMed ID: 22180706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.